Cyclohexyl isocyanate

We are Cyclohexyl isocyanate CAS:3173-53-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 3173-53-3
Product Name: Cyclohexyl isocyanate
Other Name:
Cyclohexyl isocyanate
cyclohexylisocyanate
Isocyanatocyclohexane
Isocyanic Acid Cyclohexyl Ester
cyclohexanyl isocyanate
 
Density: 1.1±0.1 g/cm3
Boiling Point: 169.0±9.0 °C at 760 mmHg
Melting Point: -80 °C
Molecular Formula: C7H11NO
Molecular Weight: 125.168
Flash Point: 48.9±0.0 °C
Exact Mass: 125.084061
PSA: 29.43000
LogP: 2.89
Vapour Pressure: 1.6±0.3 mmHg at 25°C
Index of Refraction: 1.523
Stability: Stability Flammable. Incompatible with water, strong oxidizing agents, alcohols, strong bases, amines, acids, copper alloys, aluminium. May polymerize if exposed to moisture.
Water Solubility: decomposes
 
Specification
Appearance: Colorless liquid
Assay: ≥99.0%
Water: ≤0.04%
Heavy metals: ≤20ppm
 
Application
Intermediates of Hexazinoe CAS: 51235-04-2.
Be used as pesticide intermediate, mainly used in the synthesis of the herbicide Hexazinoe.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

Cyclohexyl isocyanate


Related News: Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML).877399-00-3 Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML). O-etilhidroxilamina, hidrocloruro CAS:3332-29-4 After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply.p-tolunitrilo CAS:104-85-8 After nearly ten years of growth, China’s fine chemical industry has made considerable progress. At present, China’s overall refinement rate (that is, the output value rate of fine chemicals = total value of fine chemical products / total value of chemical products * 100%) has reached about 40%. Some fine chemical products have certain international competitiveness and become important processing and exporting places of fine chemical raw materials and intermediates in the world.After nearly ten years of growth, China’s fine chemical industry has made considerable progress. At present, China’s overall refinement rate (that is, the output value rate of fine chemicals = total value of fine chemical products / total value of chemical products * 100%) has reached about 40%. Some fine chemical products have certain international competitiveness and become important processing and exporting places of fine chemical raw materials and intermediates in the world.

Related Products
Product Name
(2S)-2-[[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-phenylpropanoyl]amino]-3-phenylpropanoic acid View Details
Ethyl 4-bromobutyrate View Details
thymogen View Details
1-Methoxy-2-propanol manufacturer 1-butyl-3-methylimidazolium trifluoromethansulfonate manufacturer 1-Ethyl-3-methylimidazolium bromide manufacturer (R)-3-Acetylthiazolidine-4-carboxylic acid manufacturer Dynorphin (1-17) manufacturer